mart-1-antigen and Bone-Marrow-Neoplasms

mart-1-antigen has been researched along with Bone-Marrow-Neoplasms* in 2 studies

Reviews

1 review(s) available for mart-1-antigen and Bone-Marrow-Neoplasms

ArticleYear
Amelanotic malignant melanoma of unknown primary origin metastasizing to the bone marrow: a case report and review of the literature.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:4

    We herein describe the case of a 77-year-old Japanese man who presented with progressive thrombocytopenia. No lymphadenopathies, bone lesions, hepatosplenomegaly or masses within any internal organs were detectable. Bone marrow smears revealed diffuse infiltration of large atypical cells morphologically resembling mature lymphoid neoplasms. A flow cytometric analysis showed that the tumor cells strongly expressed CD56 without myeloid or lymphoid antigens, suggesting that they were non-hematologic in origin. Ultimately, amelanotic malignant melanoma of unknown primary origin was diagnosed based on positive immunostaining for S100 proteins, HMB-45 and Melan-A. This case illustrates the usefulness of flow cytometric analyses for making such diagnoses. We also review the available literature on similar cases.

    Topics: Aged; Bone Marrow Neoplasms; CD56 Antigen; Fatal Outcome; Flow Cytometry; gp100 Melanoma Antigen; Humans; Immunohistochemistry; Male; MART-1 Antigen; Melanoma-Specific Antigens; Melanoma, Amelanotic; Neoplasms, Unknown Primary; S100 Proteins

2014

Other Studies

1 other study(ies) available for mart-1-antigen and Bone-Marrow-Neoplasms

ArticleYear
Amelanotic melanoma in the bone marrow.
    Blood, 2016, 07-14, Volume: 128, Issue:2

    Topics: Aged; Bone Marrow; Bone Marrow Neoplasms; Calcium-Binding Proteins; Female; gp100 Melanoma Antigen; Humans; MART-1 Antigen; Melanoma-Specific Antigens; Melanoma, Amelanotic; Neoplasm Proteins; Proto-Oncogene Proteins c-kit

2016